AN2 Therapeutics, Inc. (ANTX) vs Compugen Ltd. (CGEN)
A side-by-side comparison of AN2 Therapeutics, Inc. and Compugen Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANTX
AN2 Therapeutics, Inc.
$5.08HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
CGEN
Compugen Ltd.
$2.22HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
Total return — ANTX vs CGEN
growth of $100 · dividends reinvested · last 5yANTX -63.6% (-18.3%/yr)CGEN -29.1% (-6.7%/yr)CGEN compounded faster over this window
ANTX CGEN
ANTX vs CGEN: by the numbers
- •CGEN is the larger company ($210M vs $183M market cap).
- •CGEN is profitable (47.55% net margin) while ANTX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ANTX | CGEN |
|---|---|---|
| P/E ratio | N/A | 5.91 |
| P/S ratio | N/A | 2.84 |
| P/B ratio | 2.41 | 2.37 |
Profitability
| Metric | ANTX | CGEN |
|---|---|---|
| Gross margin | 0.00% | 86.89% |
| Operating margin | 0.00% | 40.94% |
| Net margin | 0.00% | 47.55% |
| ROE | -47.78% | 39.66% |
| ROIC | -51.01% | 26.14% |
Growth (annualized)
| Metric | ANTX | CGEN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 105.91% |
| Total return CAGR (5Y) | N/A | -18.39% |
Frequently asked
- Is ANTX or CGEN more profitable?
- CGEN runs the higher net margin — ANTX at 0.00% versus CGEN at 47.55%.
Go deeper
Dig into the metrics
Compugen P/E ratioAN2 Therapeutics ROECompugen ROEAN2 Therapeutics operating marginCompugen operating marginAN2 Therapeutics revenue growthCompugen revenue growthAN2 Therapeutics free cash flowCompugen free cash flow
AN2 Therapeutics & Compugen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.